Chiltern Announces Agreement to Acquire Theorem Clinical Research
LONDON & WILMINGTON, N.C. Chiltern, a leading global contract research organization (CRO), announced it has signed a purchase agreement to acquire Theorem Clinical Research, another leading...
View Articleチルターンがセオレム・クリニカル・リサーチの買収契約を発表
ロンドン & 米ノースカロライナ州ウィルミントン (ビジネスワイヤ) — 世界的大手医薬品開発業務受託機関(CRO)のチルターンは、別の世界的大手CROのセオレム・クリニカル・リサーチを買収する契約を締結したと発表しました。 チルターン最高経営責任者(CEO)のJim...
View ArticleChiltern Announces Agreement to Acquire Theorem Clinical Research
LONDON & WILMINGTON, N.C. Chiltern, a leading global contract research organization (CRO), announced it has signed a purchase agreement to acquire Theorem Clinical Research, another leading...
View ArticleCharlie Kinemura Joins Foresight Group as a Senior Vice President, SME on...
TOKYO Industry veteran and a leader of Argus Safety Japan (Argus J), Hisayoshi Charlie Kinemura has joined Foresight Group as Senior Vice President. With his in depth knowledge and experiences in...
View ArticleArgus Safety Japanの専門家、チャーリー・杵村、フォーサイトグループの上級副社長に就任
東京 (ビジネスワイヤ) — フォーサイトグループは、Argus Safety Japan (Argus J)に関する業界リーダーの一人である杵村・チャーリー・久仁を上級副社長として迎え入れたことを発表します。これまで培ってきたArgus Jの設計や導入に関する豊富な知識、経験を元に、杵村はフォーサイトのArgus Jをお使いの顧客に対するサービスをいっそう深化する取り組みをリードします。...
View ArticleAirware Labs Continues to Expand into New Markets with Sales in South Korea
SCOTTSDALE, Ariz. Airware Labs Corporation (OTCQB: AIRW) today announced Korea’s SHINSEGAE department stores, the leader in Korea’s modern retail industry, will now sell Airware Labs’ innovative...
View ArticleVantage mHealthcare Announces Banking Agreement with China Merchants Bank
NEW YORK Vantage mHealthcare, Inc. (OTCQB:VNTH) (“Vantage Health” or the “Company”) today announced that Nanobeak LLC, its parent company, has engaged China Merchants Bank New York for a private...
View ArticleAmpliPhi Biosciences Announces Approval of Common Stock Listing on NYSE MKT
SAN DIEGO & RICHMOND, Va. & LJUBLJANA, Slovenia, & SYDNEY AmpliPhi Biosciences Corporation (OTCQB:APHBD), a global leader in developing bacteriophage-based antibacterial therapies to...
View ArticleVantage mHealthcare宣布与中国招商银行达成银行服务协议
纽约 (美国商业资讯)–Vantage mHealthcare, Inc. (OTCQB:VNTH)(下称“Vantage Health”或“公司”)今天宣布,其母公司Nanobeak LLC已与中国招商银行纽约分行达成了发行2000万美元私募股权的中国独家服务协议。...
View ArticleBig Changes for Medtech in First Half of 2015 While Pharma Set To Break Records
LONDON & BOSTON & TOKYO The first half of 2015 has continued to confound the naysayers of the pharma industry, with deal making, venture funding and share price indices all going strong....
View ArticleRTLS Leader Sonitor Technologies Signs Distribution Agreement with Hills...
STAMFORD, Conn. Sonitor Technologies, the global RTLS technology leader, announced today that it has signed a distribution agreement with Hills Health Solutions to expand the availability of...
View Article2015 Q2 Life Sciences Hiring Index Remains near Historical High
ROCHELLE PARK, N.J. ZRG Partners has announced the findings for the second quarter Global Life Sciences Hiring Index. Hiring levels were at their highest levels yet for both the Pharma and Biotech...
View ArticleTakeda Announces European Medicines Agency Acceptance of Ixazomib’s Marketing...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application...
View Article武田薬品、欧州医薬品庁が再発性/難治性の多発性骨髄腫患者に対するイキサゾミブの販売承認申請を受理したと発表
米マサチューセッツ州ケンブリッジ & 大阪 (ビジネスワイヤ)– 武田薬品工業株式会社(TSE:...
View Article武田宣布,欧洲药品管理局已受理ixazomib用于复发/难治多发性骨髓瘤患者的市场营销授权申请
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(TSE: 4502) 今天宣布,欧洲药品管理局(EMA)已受理ixazomib用于复发/难治多发性骨髓瘤患者的市场营销授权申请(MAA),ixazomib是口服蛋白酶体抑制剂类研究药物。7月23日,ixazomib进入EMA人用药品委员会(CHMP)的加速审理,加速审理适用于具有重大公共卫生意义的药品,尤其是创新治疗药物。...
View ArticleBurning Rock and Illumina Collaborate on Molecular Diagnostics for Oncology
GUANGZHOU, China & SAN DIEGO Burning Rock and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement whereby Burning Rock will develop advanced clinical applications...
View ArticleDynoSense Closes $9.4 Million Series A Funding Round
SUNNYVALE, Calif. Digital health innovator DynoSense has announced that it has closed a $9.4 million Series A funding round, with participation from WI Harper Group; JKOM Cloud Health Technology Co;...
View ArticleMolex Delivers ISO 13485-Compliant, Medical-Grade Surgical Cables from Its...
LISLE, Ill. Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in...
View ArticleAmneal Announces New Biosciences Unit with Charles Lucarelli as President
BRIDGEWATER, N.J. Amneal today announced the creation of Amneal Biosciences, a wholly-owned subsidiary of Amneal Pharmaceuticals LLC (www.amneal.com). Amneal Biosciences will focus exclusively on...
View Article巴西A.C.Camargo癌症中心采用Masimo SpHb用于血红蛋白的无创连续监测
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布,巴西圣保罗A.C.Camargo癌症中心 已安装Masimo的无创连续血红蛋白(SpHb®)技术来监测手术患者。...
View Article